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Introduction
Laminin-2 (previously merosin) is a heterotrimeric protein made of one heavy ␣2 chain and two light chains, ␤1 and ␥1. [1] [2] [3] It is located in the basement membrane of cardiac and skeletal muscle cells, trophoblasts, 1,2 the basal keratinocytes of the dermis and epithelial cells of hair follicles, 4 thymic epithelial cells, Schwann cells, 1 and cells of mesenchymal origin. 1, 4, 5 Laminins have a cross-like tridimensional structure which interacts with cellular receptors, and are a part of the molecular network linking the subsarcolemmal cytoskeleton to the extracellular matrix in skeletal muscle. [6] [7] [8] The laminin ␣2 chain is expressed in vitro by myogenic cells and its mRNA expression is developmentally regulated in the mouse. 4, 9 Laminin-2 is required in vitro for myogenesis and myotube stability and survival. 10, 11 The laminin ␣2 chain is absent or reduced in a subgroup of congenital muscular dystrophy patients 12 having mutations in the laminin ␣2 gene. [13] [14] [15] This ␣2 chain is also absent or dramatically reduced in the dystrophia muscularis (dy/dy) mouse model which develops early and severe muscular dystrophy. [16] [17] [18] [19] The number and diameter of muscle fibers are greatly variable in dy/dy mouse, but are always inferior to normal values. Also, the muscles show marked increase in connective tissue. The milder allelic variant, the dy 2J /dy 2J mouse model, 20 has an identified mutation on the laminin ␣2 chain gene which leads to the synthesis of a truncated protein. 21, 22 Two knock-out mouse models have been described recently. 23, 24 We have shown previously that the transplantation of primary mouse muscle cell cultures partially restored laminin ␣2 chain expression in dy/dy mice. 25 However, due to the heterogenous nature of these primary cultures, it was not possible to identify unambiguously the cell type responsible for this laminin ␣2 chain restoration. In an attempt to investigate this question, we transplanted fibroblast cell lines and conditionally immortalized myogenic cell lines into dy/dy mouse muscles. The fibroblast cell lines were unable to restore laminin ␣2 chain in vivo. The conditionally immortalized myoblast cell lines gave limited success, despite their potential to express a myogenic phenotype in vitro. This result could well be related to the inability of SV40 T antigen-immortalized cell lines to undergo late differentiation as recently reported in other models. 26, 27 In the present study, we reinvestigated the origin of laminin ␣2 chain following cell transplantation using normal, non-immortalized human myoblasts as well as various mouse myogenic cell lines. The human myoblasts were transplanted into immunodeficient SCID mice to investigate human laminin ␣2 chain expression in vivo.
The permanent G8 mouse myoblast cell line 28 was used for allotransplantation into immunosuppressed dy/dy mouse muscles to investigate murine laminin ␣2 chain restoration in the animal model of congenital muscular dystrophy. As a control, the permanent D7 mouse myoblast cell line of dy/dy origin 29 was transplanted into immunosuppressed dy/dy mouse muscles. These mouse cell lines were engineered in vitro for ␤-galactosidase expression to follow the fate of the cells following implantation. Our data show that pure populations of myogenic cells synthesize the laminin ␣2 chain which participates in the formation of laminin-2 around new and hybrid muscle fibers following transplantation.
Results

Human myoblast transplantations
Human non-immortalized myoblast clones were prepared independently from healthy donors 30 and transplanted into SCID mice ( Table 1) . As shown in Figure 1 , 1 month after transplantation, the human laminin ␣2 chain was detected around small, medium and normal diameter muscle fibers at the injection sites using the 5H2 antibody which does not react with mouse laminin-2 ( Figure 1a and b) . 24 Large clusters of muscle fibers expressing the human laminin ␣2 chain were observed (Figure 1a and c) . However, it must be noted that no human laminin ␣2 was expressed by muscle fibers located at a distance from the injection sites in the tibialis mouse muscle (Figure 1a ), indicating: (1) that the pure human cells did not repopulate the whole mouse muscle, and (2) that the distribution of the human proteins was restricted to the injection site. Human dystrophin expression, detected on serial sections using the NCLDys3 antibody which does not react with mouse dystrophin, 31 colocalized with the human laminin ␣2 chain at the same sites of injection (Figure 1c and d) . In some cases, the human laminin ␣2 chain was detected around muscle fibers that did not contain human dystrophin. This probably reflects the difference in behavior between laminin ␣2, which is part of the secreted lami- D7LNB1 n = 6 mouse laminin ␣2 chain and ␤-galactosidase (colocalization) n = 6 C57BL6J +/+ D7LNB1 n = 5 mouse laminin ␣2 chain and ␤-galactosidase (colocalization) n = 5 a n gives the number of tibialis anterior injected.
nin-2 complex, and dystrophin, which is a subsarcolemmal membrane-bound protein. It should be emphasized that quantitative variations existed from animal to animal but independent myoblast cultures obtained from different human donors gave similar results. Taken together, our data indicate that the transplantation of pure myoblasts leads to the expression of laminin-2 in vivo in nondystrophic muscle.
Mouse myoblast transplantations
Since the dystrophia muscularis model of congenital muscular dystrophy has not been developed in an immunodeficient (SCID) background, we investigated laminin ␣2 chain expression in immunocompetent dy/dy mice following transplantation of the mouse myogenic cell lines G8, MB3 and D7. These cells were also labeled with a retroviral vector containing the bacterial ␤-galactosidase transgene (LNPOZ) 32 in order to follow their fate after transplantation, which resulted in the creation of G8LN, MB3LN and D7LNB1 cell lines, in which both myoblasts and myotubes expressed a cytoplasmic ␤-galactosidase.
G8 and G8LN myoblast transplantation into dy/dy mice First, the G8 and G8LN myoblasts 28 were transplanted in the tibialis anterior of the FK506-immunosuppressed dy/dy mice 33 and the mouse laminin ␣2 chain was detected using a polyclonal antibody. 1 The transplantation induced the expression of the laminin ␣2 chain in the muscles of all animals ( Figure 2a) . However, the injection of two million G8 cells only resulted in the formation of a few hundred myotubes and muscle fibers of different sizes which were restricted to the injection site and surrounded by the laminin ␣2 chain (Figure 2a ). This indicated that the cells not only did not migrate far from the deposition site but also that the laminin ␣2 chain was probably not exported far from the site of synthesis. As expected, the restoration of the laminin ␣2 chain was also observed following transplantation of the tagged G8LN myoblasts. Both the intracellular marker ␤-galactosidase ( 
Figure 1 Co-expression of the human laminin ␣2 chain and human dystrophin in muscle of immunodeficient SCID mouse following human myoblast transplantation. Peroxidase immunohistochemistry for laminin ␣2 chain (a-c) and dystrophin (d). (c) and (d) are serial sections (asterisks identify the same fibers) and both laminin ␣2 chain and dystrophin were detected (large arrows). Some fibers did not express dystrophin but expressed the laminin ␣2 chain (c, d). In (a), H indicates a cluster of fibers expressing the human laminin-2, surrounded by M which is a zone of muscle fibers not expressing the human laminin-2 and presumably of mouse orgin. Laminin ␣2 chain expression around the fibers was sometimes patchy and irregular and some infiltrating cells were present (b, thin arrows). Original magnification: 100× (a), 400× (b), 270× (c, d).
ial sections, but still restricted to the injection site. Hence, this result confirmed that the spreading of the injected cells was poor but, more importantly, indicated that diffusion of laminin-2 was almost negligible in vivo. It is worth noting that 1 month after transplantation, unfused G8LN cells were still present (Figure 2b ), thus indicating that they can survive for long periods within the muscle tissue.
MB3LN myoblast transplantation into dy/dy mice
We previously reported that conditionally immortalized MB3 myogenic cells were incapable of forming myofibers expressing laminin ␣2 following transplantation. 25 In the MB3 cell line, ␤-galactosidase is expressed only in differentiated myotubes and muscle fibers, but not myoblasts. To investigate the reason for the failure of laminin ␣2 chain expression, MB3 cells were labeled using the LNPOZ retroviral vector and transplanted in a series of dy/dy muscles. In agreement with our previous results, little laminin ␣2 chain expression was observed around the rare blue muscle fibers (Figure 2 h ). More interestingly, no unfused cells expressing ␤-galactosidase could be found 1 month after transplantation (Figure 2 g ), which suggests that MB3LN cells have been eliminated following transplantation. These results indicated that these SV40-immortalized cell lines contributed poorly to laminin-2 restoration in vivo.
D7LNB1 myoblast transplantation into normal, dy/dy and dy
2J
/dy 2J mice Lastly, a series of experiments was designed to test whether expression of the laminin ␣2 chain was a prerequisite for exogenous myogenic cells to participate in the formation of myofibers following transplantation. To achieve this, we used the D7 myogenic cell line derived from a dystrophic animal. 29 These cells grow efficiently on gelatin-coated Petri dishes and form giant, self-contracting myotubes upon differentiation. We derived a variant of this cell line using the LNPOZ retroviral vector and selected a clone (D7LNB1) based on its ability to express a high level of ␤-galactosidase activity (Figure 3a ers which were identified by the presence of the ␤-galactosidase transgene (Figure 3g ). As expected, no laminin-2 expression was detected surrounding either the host, the donor or the hybrid myofibers (Figure 3h) . Thus, this last experiment unambiguously proved that the presence of laminin-2 is not essential for the formation of myofibers.
Discussion
Myoblast transplantation leads to laminin-2 expression in vivo Our transplantation experiments using both human and mouse myogenic cells provide evidence that pure muscle cells are able to synthesize laminin ␣2 chains which consequently participate in the secretion of laminin-2 around the new and hybrid muscle fibers formed at the injection site. The expression of laminin ␣2 chain was obtained both in non-dystrophic SCID muscles and in the dystrophic muscles of the animal model of congenital muscular dystrophy.
In addition to LAMA2, other genes or transgenes conveyed by the donor myoblasts were also expressed upon fusion in the recipient muscles. Indeed, human dystrophin and ␤-galactosidase expression were observed following injection of myoblasts into mouse muscles. The expression of these proteins was colocalized and restricted to the injection site. Interestingly, these proteins presented differential localization in some cases, with the human laminin ␣2 chain being expressed on a larger number of fibers than human dystrophin (see Figures 1c  and d) . It is tempting to propose that laminin-2 molecules were deposited further from a human nucleus than can be travelled by dystrophin. More interestingly, these laminin-2 molecules may have been secreted by a neighboring myofiber containing human nuclei and therefore laminin-2 may have migrated among muscle fibers. Laminin-2 and dystrophin, however, do present intrinsic differences such as molecular weight and subcellular localization, which may account for the differential detection of the proteins observed in some cases, as illustrated in a previous study in another model. 34 Our present results indicate mainly that the distance of migration would be limited, since most of the fibers displaying the presence of laminin-2 were restricted to the injection sites.
The restoration of the laminin ␣2 chain was observed in a previous study following the transplantation of heterogeneous primary cultures. Comparison between the amounts of laminin ␣2 obtained in the present study to those presented in this previous one 25 is difficult, since intrinsic differences between the cells and the animal models introduce important variations. Such variations were already reported using newborn primary cultures. 25 However, most of the fibers at the injection site, as identified by dystrophin or ␤-galactosidase staining, were surrounded by laminin-2. Therefore, it is tempting to suggest that muscle cells are the main source of the laminin ␣2 chain and that other cell types (fibroblasts, myofibroblasts, Schwann cells) contribute little to the formation of the basal lamina of the muscle fibers following muscle regeneration, even though a number of studies have shown their potential to express some laminins in other tissues. 1, 35, 36 It still remains questionable which of the myoblasts, myotubes or muscle fibers are the main laminin-2 secreting cell in vivo. Unfused myoblasts are unlikely to contribute solely to laminin-2 expression in vivo, since in vitro studies have shown that the extracellular expression of laminin-2 occurred after the formation of the myotubes. 4, 10 Muscle regeneration following myoblast transplantation The extent of muscle formation upon transplantation was variable between mice, and myoblasts did not repopulate the whole injected muscle. In the mdx/mdx mouse model of Duchenne muscular dystrophy, the transplantation of newborn primary cultures led to the regeneration of 30-90% of the muscle. 33, [37] [38] [39] In the present study, however, the transplantation of G8 and D7 myoblasts in the dy/dy mouse model of congenital muscular dystrophy led to the formation of a few hundred muscle fibers in the dy/dy mice. Many factors may account for the difference observed between these models: (1) The nature of the myogenic cell, since G8 and D7 cells may not present exactly the same characteristics as newborn cells. (2) The presence of other cells contained only in the primary cultures which may have influenced muscle regeneration or cell migration. (3) The muscle model, since the dy/dy muscles show extensive fibrosis and poor spontaneous regeneration. 16 (4) Finally, the extent of acute cell death following injection hampers the success of cell transplantation. Both the nonspecific inflammatory reactions conveyed by neutrophils 40, 41 and the nature of the cells injected 42 are involved in the premature loss of transplanted myoblasts. The differential susceptibility of various myogenic cells to acute cell death has been reported recently in other models. 42 In our study, a few ␤-galactosidase-positive muscle fibers and no ␤-galactosidasepositive cells were observed following transplantation of SV-40 conditionally immortalized cells, indicating that these cells may have disappeared early. In contrast, some G8LN and D7LNB1 cells were still observed 1 month after transplantation. Although the extent of cell death has not been specifically explored in dy/dy animals, our results indicate that different cell lines presented different susceptibility to cell death within muscle tissue.
The roles played by laminin-2 during embryogenesis or muscle regeneration have not yet been fully elucidated. Indeed, the muscles of dystrophic animals, both spontaneous mutants and knock-out models, are formed at birth, but present regeneration defects. 23, 24 Our data, however, clearly indicate that myotubes and myofibers were formed in vivo in the absence of detectable amounts of the laminin ␣2 chain and thus suggest that the presence of laminin-2 is not an absolute prerequisite for myoblast fusion in vivo. Interestingly, the lack of laminin-2 did not increase acute cell death following cell injection, since D7LNB1 cells survived and were able to participate in muscle regeneration.
Myoblasts as versatile candidates for in vivo or ex vivo restoration of extracellular proteins
Our results indicate that successful myoblast transplantation leads to the expression of several proteins in the host muscle fiber, including the extracellular laminin-2, although cell spreading and diffusion of the protein are still restricted to the injection site. In the present study, the immunosuppression of the dystrophic animals was required to control the rejection of allogeneic cells. To avoid this problem, ex vivo gene therapy approaches should be developed, and the in vitro engineering of dystrophic myoblasts for the expression of the therapeutic ␣2 chain gene is currently under investigation. 43, 44 The understanding and control of premature cell death following injection should also be beneficial to overall transplantation results. Indeed, the success of myoblast transplantation has been recently improved by manipulating the immune response [40] [41] [42] 44, 45 or the biochemical adequacy between the donor cell and the recipient muscle 42 in other mouse models. Moreover, the results have also been improved using protocols increasing cell scattering in vivo, such as repeated injections or activation by concanavalin A. [46] [47] [48] The transfer of such protocols into the dy/dy model may promote a more widespread and homogenous laminin ␣2 chain restoration and tissue regeneration through the dy/dy muscle following myoblast transplantation.
Materials and methods
Preparation of human myoblasts
Human muscle biopsies were dissociated with collagenase (type IA; Sigma, St Louis, MO, USA) and trypsin-EDTA and then cloned as previously described. 30 One muscle biopsy provided hundreds of clones. The myogenic cells were characterized on the basis of the expression of NCAM antigen 49 and expanded. Each clonal population was tested for desmin expression and myoblast fusion in vitro. Each clone was not expanded over 10 6 cells. Myogenic populations were then gathered to obtain a consistent important pool of myoblasts. The human myoblasts originating from two healthy donors have been used in previous experimental or clinical trials.
30,31
Preparation of mouse myoblasts The G8 myoblasts were preferred to C2 mouse myoblasts which were reported to be tumorigenic in vivo. 50 The G8 myoblasts (ATCC, Rockville, MD, USA) 28 were grown in DMEM high glucose with 10% FCS, 10% HS and 1% of a solution of penicillin and streptomycin (all products from Gibco BRL, Gaithersburg, MD, USA). These cells were passaged every other day before reaching confluency using trypsin-EDTA at a split ratio of 1:6. The cells were used at less than 10 passages after reception from the ATCC (original passage number unknown). The day of transplantation, cells were harvested using trypsin-EDTA, washed three times in HBSS and kept on ice. Viability was assessed using trypan blue.
The MB3 cells were previously described. 25 They express both the SV40 T antigen under control of an inducible promoter, and the ␤-galactosidase under control of the quail fast troponin I promoter.
The D7 cell line was obtained by Yaffe and Saxel 29 from the primary culture of an adult 129REJ dy/dy mouse. The cells were grown in DMEM (Gibco) supplemented with 20% FCS (Gibco) on to gelatin-coated dishes (0.1%, Sigma).
The G8LN, MB3LN and D7LNB1 cells were obtained by stable transfection of G8 cells, MB3 cells or D7 with the LNPOZ retroviral vector carrying the lacZ gene and the neomycin resistance gene (a kind gift of Dr C Cepko, Harvard, Boston, MA, USA). 32 Cells at 20% confluence were incubated with the culture supernatant containing the LNPOZ vector for 3 h in the presence of 8 g/ml polybrene (Sigma). Preliminary experiments indicated that nontransformed cells were sensitive to 50 g/ml geneticin (Gibco) and over. The transfected cells were selected for 2 weeks using 400 g/ml geneticin and further maintained in 50 g/ml.
The D7LNB1 cells were obtained by cloning. Following transfection and selection, 16 of 29 clones did not express significant amounts of ␤-galactosidase and were discarded. Twelve of the 13 remaining clones expressed ␤-galactosidase in myoblasts and/or in myotubes and only one clone did not retain myogenicity. Based on the high expression of ␤-gal in both myoblasts and myotubes, the D7LNB1 clone was retained for the in vivo experiments presented here. Three other clones gave similar results.
Cell transplantation and muscle pretreatment About 2 × 10 6 viable human myoblasts were injected in both tibialis anterior muscles of 6-week-old SCID mice (Jackson Laboratories, Bar Harbor, ME, USA) as described elsewhere. 31 As pretreatment of the muscle, the left leg of some mice received 20 Gy irradiation 2 days before transplantation and the tibialis anterior of the same leg received 50 ng of the myonecrotic drug notexin 1 day before the first transplantation 31 and was injected twice at a 1 week interval.
About 2 × 10 6 viable G8, G8LN or MB3LN cells were injected in both tibialis anterior of 4-to 6-week-old C57BL/6J dy/dy mice (breeders dy/+ from Jackson Laboratories). The left tibialis anterior of some mice received irradiation and notexin pretreatments as above. 
Immunosuppression
Immunosuppression was not required in the model of xenogenic myoblast transplantation into immunodeficient SCID mice. Immunosuppression was required in all allogenic experimental models, ie G8, G8LN, MB3LN and D7LNB1 cell transplantations into normal, dy/dy and dy 2J /dy 2J mice. Immunosuppression was started on the transplantation day using FK506 2.5 mg/kg/day i.m. (Fujisawa, Osaka, Japan). 33 
Preparation of muscle biopsies
The animals were killed 4 weeks after transplantation and perfused with isotonic saline solution. The muscles were immersed in 30% sucrose for 18 h and frozen in liquid nitrogen. The 8 m sections were prepared using a cryostat.
Laminin-2 and dystrophin immunohistochemistry
The human laminin ␣2 chain was detected with the monoclonal 5H2 antibody (Chemicon, Temecula, CA, USA). Mouse laminin ␣2 chain was detected with rabbit polyclonal anti-mouse laminin ␣2 chain, kindly provided by Dr E Engvall (Burnham Institute, La Jolla, CA, USA). 1 The staining was detected either with peroxidase-labeled second antibody, H 2 O 2 and diaminobenzidine or with FITC-labeled second antibody as previously described. 33 Human dystrophin was detected with the monoclonal NCLDys3 antibody (Novocastra, Newcastle upon Tyne, UK) and peroxidase-diaminobenzidine staining as described. 131 The antibodies directed against human antigens do not cross-react with the mouse antigens.
␤-Galactosidase histochemistry
Following a short glutaraldehyde fixation (0.25%) and two rinses in PBS, the cryostat sections were incubated overnight in the presence of X gal reagent (5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside; Boehringer Mannheim, Laval, Canada) at room temperature. 33 Histochemical cholinesterase staining The cholinesterase activity was observed following histochemical staining according to Koelle and Friedenwald. 51 Briefly, the slides previously used for ␤-galactosidase staining were fixed in 2.5% glutaraldehyde for 1 h on ice, then incubated for 15 min in a solution containing acetic acid (0.1 m), sodium acetate (0.1 m), glycine (25 mm) and cupric sulphate (5 mm) in a Soerensen buffer. Then the slides were incubated in the same solution also containing acetylthiocholine iodide (4 mm) for 45 min. Following one rinse in water, the slides were incubated in ammonium sulfide (1%) for a few minutes and rinsed in water. Cholinesterase activity is characterized by a brown staining.
